QBD-BASED DEVELOPMENT OF ORODISPERSIBLE FILMS OF ANTIPSYCHOTIC DRUGS

Authors

DOI:

https://doi.org/10.22159/ijap.2022v14i5.45300

Keywords:

Quality by Design, Orodispersible films, Antipsychotic drugs

Abstract

This review provides an overview of the application of the Quality by Design (QbD) approach in the formulation and evaluation of the orodispersible films (ODFs) of antipsychotic drugs. Quality by Design involves a well-defined approach with predefined objectives to develop the product or process based on quality risk management and sound science. It comprises the defining of Quality Target Product Profile (QTPP) and Critical Quality Attributes (CQAs), risk assessment, design and development, and evaluation of formulation. The Orodispersible films are ultra-thin, elegant, and portable dosage forms that do not require water to be ingested. It can be used for individuals who require special needs, such as for treating psychosis, schizophrenia, mania, and dysphagia. Hence, it holds tremendous potential in terms of patient compliance, convenience, and pharmacotherapy. They are fabricated by different techniques, which include solvent casting, hot-melt extrusion, 3D printing, and others discussed here. They are evaluated for different attributes like mechanical strength, dissolution, disintegration, tensile strength, folding endurance, and others discussed here. It also provides the significance of stability, packaging, shapes, and patent-related concepts of orodispersible films.

Downloads

Download data is not yet available.

References

Quality by Design (QbD) in Pharmaceutical industry. [Internet]. [cited 202Mar.15]. https://www.pharmatutor.org/articles/quality-by-design-qbd-in-pharmaceutical-industry-tools-perspectives-and-challenges.

Bhoop BS. Quality by Design (QbD) for holistic pharma excellence and regulatory compliance. Pharm Times. 2014; 46(8):26-33.

Sheela A, Haque SE. Development of polymer-bound fast-dissolving metformin buccal film with disintegrants. International Journal of Nanomedicine. 2015;:199.

, Bala R, Khanna S, Pawar P, Arora S. Orally dissolving strips: A new approach to oral drug delivery system. Int. J. Pharm. Invest.. 2013; 3:67.

Adriany R, Anwar EF, Andrajati R, Hanafi M. Formulation of orodispersible tablet of luffa acutangula (L) roxb using novel co-processed via spray dried excipient. Int. J. Pharm. Pharm. Sci. 2015 Jan 1; 7(1):124-9

Das PS, Verma S, Saha P. Fast Dissolving Tablet Using Solid Dispersion Technique: A Review. International Journal of Current Pharmaceutical Research. 2017; 9:1.

Tho I. Smeltetabletter - Fordeler og ulemper. Tidsskrift for Den norske legeforening 2012; 132(4):424–5.

Liew KB, Tan YTF, Peh KK. Characterization of Oral Disintegrating Film Containing Donepezil for Alzheimer Disease. AAPS PharmSciTech. 2011; 13:134-142.

Singh S, Virmani T, Virmani R, Mahlawat G, Kumar P. Fast Dissolving Drug Delivery Systems: Formulation, Preparation Techniques and Evaluation. Univ J Pharm Res. 2018; 3.

Cilurzo F, Musazzi UM, Franzé S, Selmin F, Minghetti P. Orodispersible dosage forms:

biopharmaceutical improvements and regulatory requirements. Drug Discov Today 2018; 23:251-259.

NCI Thesaurus [Internet]. [cited 2022Mar.8]. https://ncithesaurus.nci.nih.gov/.

In-process revision vol. 35(5) [sept.–oct. 2009] - USP–NF [Internet]. [cited 2022Mar17]. Available from: https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/pharmaceuticalDosageForms.pdf.

Ph.Eur 9.3, Oromucosal Preparations, in: European Pharmacopoeia Commission (Ed.), European Pharmacopoeia. European Directorate for the Quality of Medicines &Healthcare (EDQM), Strasbourg, France, 2018.

Gupta A, Kumar J, Verma S, Singh H. Application of Quality by Design Approach for the Optimization of Orodispersible Film Formulation. Asian J. Pharm. Clin. Res. 2018; 11:8.

Meghana R. An Overview on Mouth Dissolving Film Asian J. Pharm. Clin. Res. 2018; 11:44-47.

Frederic Deadman LL. New impregnated or coated films. 1967.

Fuchs P, Hilmann J. Medicament carriers in the form of film having active substance incorporated therein. 1979.

Pham CL, Wood AJ, Lambert MB, Carpenter W. Palatal erythema in patients using Listerine Cool Mint PocketPaks Oral Care Strips: case reports. J Dent Child (Chic). 2005 May-Aug; 72(2):52-5.

outsourcing-pharma.com. 2022. Zengen claims a first with drug-laden oral strip. [online] Available at: <https://www.outsourcingpharma.com/Article/2003/08/25/Zengen-claims-a-first-with-drug-laden-oral strip#:~:text=(APIs). active%20pharmaceutical%20ingredients%20(APIs).>28.[Accessed March 9, 2022].

Preis M. Orally disintegrating films and mini-tablets—innovative dosage forms of choice for

pediatric use. AAPS PharmSciTech. 2015; 16(2):234–41.

Reindel KL, DeAngelis MJ, Ferrara AS, Conn KM, Phillips EM, Corigliano AT, Zhao F. An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability. Int J Pharm Compd. 2019 May-Jun; 23(3):258–263.

Tripathi KD. Essentials of Medical Pharmacology. New Delhi: Jaypee Brothers Medical

Publishers (P), Ltd.; 2013.

.Bülbül EÖ, Mesut B, Cevher E, Öztaş E, Özsoy Y. Product transfer from lab-scale to pilot-scale of quetiapine fumarate orodispersible films using quality by design approach. J Drug Deliv Sci Technol. 2019 Dec 1; 54:101358.

Jani R, Patel D. Hot melt extrusion: An industrially feasible approach for casting Orodispersible Film. Asian J. Pharm. Sci. 2015; 10(4):292–305.

European Medicines Agency. 2006. ICH Q9 Quality risk management - European Medicines Agency. [online] Available at: <https://www.ema.europa.eu/en/ich-q9-quality-risk-management> [Accessed June 16, 2022].

Krull, S., Susarla, R., Afolabi, A., Li, M., Ying, Y., Iqbal, Z., Bilgili, E. and Davé, R., 2015. Polymer strip films as a robust, surfactant-free platform for delivery of BCS Class II drug nanoparticles, Int. J. Pharm, 489(1–2), pp.45-57.

Krull SM, Patel HV, Li M, Bilgili E, Davé RN. Critical material attributes (cmas) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of Plasticizer on film properties and dissolution. Eur. J. Pharm. Sci. 2016; 92:146–55.

Scarpa M, Paudel A, Kloprogge F, Hsiao WK, Bresciani M, Gaisford S, Orlu M. Key acceptability attributes of Orodispersible Films. Eur. J. Pharm. Biopharm. 2018; 125:131–40.

Thabet Y, Breitkreutz J. Orodispersible films: Product transfer from lab-scale to continuous manufacturing. Int. J. Pharm. 2018; 535(1–2):285–92.

BioProcess International. 2022. Practical Considerations for DoE Implementation in Quality By Design - BioProcess International. [online] Available at: <https://bioprocessintl.com/manufacturing/information-technology/practical-considerations-for-doe-implementation-in-quality-by-design-297328/>.

Arya A, Chandra A, Sharma V, Pathak K. Fast dissolving oral films: an innovative drug delivery system and dosage form. Int J ChemTech Res. 2010 Jan; 2(1):576–83.

Bhyan B, Jangra S, Kaur M, Singh H. Orally fast dissolving films: innovations in formulation and technology. Int J Pharm Sci Rev Res. 2011 Jul; 9(2):9–15.

Dixit RP, Puthli SP. Oral Strip Technology: Overview and future potential. J Control Release. 2009; 139(2):94–107.

Siddiqui MN, Garg G, Sharma PK. A short review of “A novel approach in oral fast dissolving drug delivery system and their patents”. Adv Biol Res. 2011; 5(6):291–303.

Dhere PM, Patwekar SL. Review on preparation and evaluation of oral disintegrating films. IJPT. 2011; 3(4):1572–85.

Bhura N, Sanghvi K, Patel U, Parmar B, Patel D. A review on fast dissolving film. IJPRBS. 2012; 1(3):66–89.

Dahiya M, Saha S, Shahiwala A. A review on Mouth dissolving films, Curr Drug Deliv. 2009; 6(5):469–76.

Gupta MM, Patel MG, Kedawat M. Enhancement of dissolution rate of rapidly dissolving oral film of meclizine hydrochloride by complexation of Meclizine hydrochloride with ß-cyclodextrine. J. Appl. Pharm. Sci. 2011; 1 (9) 150–153.

Smriti T. Mouth dissolving films: A review. Int J Pharma Bio Sci. 2013 Jan;4:899-908.

Murata Y, Isobe T, Kofuji K, Nishida N, Kamaguchi R. Preparation of Fast Dissolving Films for Oral Dosage from Natural Polysaccharides. Materials (Basel). 2010 Aug 9; 3(8):4291–4299.

Patel K, Soni S, Patel R, Pandya V, Bharadia P. Mouth dissolving film: a review. Int. J. Pharm. Res. Scholars. 2012; 1(3):154–63.

Kumar SV, Gvaskar B, Sharan G, Rao YM. Overview On Fast Dissolving Films. Int. J. Pharm. Pharm. Sci. 2010; 2 (3): 2933.

Panchal MS, Patel H, Bagada A, Vadalia KR. Formulation and evaluation of mouth dissolving film of ropinirole hydrochloride by using pullulan polymers. IJPRAS. 2012; 1(3):60–72.

Borges AF, Silva C, Coelho JF, Simões S. Oral films: Current status and future perspectives II - Intellectual property, technologies, and market needs. J Control Release. 2015 May 28; 206:108-21.

Patent portfolio for pharmfilm® [Internet]. Aquestive. 2018 [cited 2022Mar16]. Available from: https://aquestive.com/canadian-patent-portfolio-for-pharmfilm/

Seoulpharmaceuticals.com. 2022. 서울제약. [online] Available at: <http://www.seoulpharmaceuticals.com/sub/sub1010.asp#expertize02> [Accessed March 16, 2022].

Borges AF, Silva C, Coelho JF, Simões S. Oral films: Current status and future perspectives: I - Galenical development and quality attributes. J Control Release. 2015 May 28; 206:1-19.

Carolina Visser J, Weggemans OAF, Boosman RJ, Loos KU, Frijlink HW, Woerdenbag HJ. Increased drug load and polymer compatibility of bilayered orodispersible films. Eur J Pharm Sci. 2017 Sep 30; 107:183-190.

Visser JC, Woerdenbag HJ, Crediet S, Gerrits E, Lesschen MA, Hinrichs WLJ, Breitkreutz J, Frijlink HW. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations. Int J Pharm. 2015 Jan 15; 478(1):155–163.

Łyszczarz E, Brniak W, Szafraniec-Szczęsny J, Majka TM, Majda D, Zych M, Pielichowski K, Jachowicz R. The Impact of the Preparation Method on the Properties of Orodispersible Films with Aripiprazole: Electrospinning vs. Casting and 3D Printing Methods. Pharmaceutics. 2021 Jul 22; 13(8):1122.

Illangakoon UE, Gill H, Shearman GC, Parhizkar M, Mahalingam S, Chatterton NP, Williams GR. Fast dissolving paracetamol/caffeine nanofibers prepared by electrospinning. Int J Pharm. 2014 Dec 30; 477(1–2):369–79.

Rustemkyzy C, Belton P, Qi S. Preparation and Characterization of Ultrarapidly Dissolving Orodispersible Films for Treating and Preventing Iodine Deficiency in the Pediatric Population. J Agric Food Chem. 2015 Nov 11; 63(44):9831–8.

Luraghi A, Peri F, Moroni L. Electrospinning for drug delivery applications: A review. J Control Release. 2021 Jun 10; 334:463-484.

Cilurzo F, Cupone IE, Minghetti P, Selmin F, Montanari L. Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm. 2008 Nov; 70(3):895–900.

Maniruzzaman M, Boateng JS, Snowden MJ, Douroumis D. A review of hot-melt extrusion: process technology to pharmaceutical products. ISRN Pharm. 2012; 2012:436763.

Pimparade MB, Vo A, Maurya AS, Bae J, Morott JT, Feng X, Kim DW, Kulkarni VI, Tiwari R, Vanaja K, Murthy R, Shivakumar HN, Neupane D, Mishra SR, Murthy SN, Repka MA. Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology. Eur J Pharm Biopharm. 2017 Oct; 119:81-90.

Alomari M, Mohamed FH, Basit AW, Gaisford S. Personalised dosing: Printing a dose of one's own medicine. Int J Pharm. 2015 Oct 30; 494(2):568-577.

Jamróz W, Kurek M, Łyszczarz E, Szafraniec J, Knapik-Kowalczuk J, Syrek K, Paluch M, Jachowicz R. 3D printed orodispersible films with Aripiprazole. Int J Pharm. 2017 Nov 30; 533(2):413–420.

Musazzi UM, Selmin F, Ortenzi MA, Mohammed GK, Franzé S, Minghetti P, Cilurzo F. Personalized orodispersible films by hot melt ram extrusion 3D printing. Int J Pharm. 2018 Nov 15; 551(1-2):52-59.

Sjöholm E, Sandler N. Additive manufacturing of personalized orodispersible warfarin films. Int J Pharm. 2019 Jun 10; 564:117-123.

Khalid GM, Musazzi UM, Selmin F, Franzè S, Minghetti P, Cilurzo F. Extemporaneous printing of diclofenac orodispersible films for pediatrics. Drug Dev Ind Pharm. 2021 Apr; 47(4):636-644.

Myers GL, Hilbert S. D, Boone BJ, Bogue AB, Sanghvi P, Hariharan M. Sublingual and buccal film compositions . 2013.

Niese S, Quodbach J. Formulation development of a continuously manufactured orodispersible film containing warfarin sodium for individualized dosing. Eur J Pharm Biopharm. 2019 Mar; 136:93-101.

Schmitz C, Bauer M, Linn M. U-shaped oral thin film. 2019.

Wood R, Mao H-Q, KEET C, Martin R. Orally dissolving thin films containing allergens and methods of making and use. 2013.

Daud AS, Bonde MN, Sapkal NP. Development of zingiber officinale in oral dissolving films: Effect of polymers on in vitro, in vivo parameters and clinical efficacy. Asian J Pharm. 2011; 5(3):183.

Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. In vitro techniques to evaluate buccal films. J Control Release. 2013 Feb 28; 166(1):10-21.

Liew KB, Tan YT, Peh KK. Characterization of oral disintegrating film containing donepezil for Alzheimer disease. AAPS PharmSciTech. 2012 Mar; 13(1):134-42.

Sievens-Figueroa L, Bhakay A, Jerez-Rozo JI, Pandya N, Romañach RJ, Michniak-Kohn B, Iqbal Z, Bilgili E, Davé RN. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications. Int J Pharm. 2012 Feb 28; 423(2):496-508.

Lakshmi PK, Sridharan A, Sreekanth J. Formulation development of fast releasing oral thin films of Levocetrizine dihydrochloride with eudragit®epo and optimization through Taguchi Orthogonal Experimental Design.

Asian J Pharm 2011; 5(2):84.

Gupta MS, Kumar TP. Characterization of Orodispersible Films: An Overview of Methods and Introduction to a New Disintegration Test Apparatus Using LDR - LED Sensors. J Pharm Sci. 2020 Oct; 109(10):2925-2942.

Ahmed MG, Charyulu RN, Harish NM, Prabhu P. Formulation and in-vitro evaluation of chitosan films containing tetracycline for the treatment of periodontitis. Asian J Pharm. 2009; 3(2):113.

Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv. 2011 Mar; 8(3):299-316.

Yir-Erong B, Bayor MT, Ayensu I, Gbedema SY, Boateng JS. Oral thin films as a remedy for noncompliance in pediatric and geriatric patients. Ther Deliv. 2019 Jul; 10(7):443-464.

Senta-Loÿs Z, Bourgeois S, Briançon S, Fessi H. Characterization and Stability Study of tetrabenazine loaded in Orodispersible Films for Pediatric therapy. Int. J. Pharm. 2018; 536(2):503–4.

Gupta S, Kumar TP, Gowda DV. Patent Perspective on Orodispersible Films. Recent Pat Drug Deliv Formul. 2020; 14(2):88-97.

Published

19-07-2022

How to Cite

M. P., G., S. K., M., & GOWDA, D. V. (2022). QBD-BASED DEVELOPMENT OF ORODISPERSIBLE FILMS OF ANTIPSYCHOTIC DRUGS. International Journal of Applied Pharmaceutics, 14(5). https://doi.org/10.22159/ijap.2022v14i5.45300

Issue

Section

Review Article(s)

Most read articles by the same author(s)